Clinical trial
The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors…
NCT04572633 · HistoSonics, Inc., Industry · Active, not recruiting
Key facts
| NCT number | NCT04572633 |
|---|---|
| Title | The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy |
| Official title | The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy (#HOPE4LIVER US) |
| Acronym | #HOPE4LIVER US |
| Lead sponsor | HistoSonics, Inc., Industry |
| Status | Active, not recruiting |
| Study type | Interventional |
| Conditions | Liver Neoplasms, Hepatocellular Carcinoma, Liver Metastases |
| Intervention type | Device |
| Interventions | HistoSonics System |
| Enrollment | 47 |
| Start date | Jan 27, 2021 |
| Primary completion | Jan 9, 2023 |
| Completion | Sep 1, 2027 |
| First posted | Oct 1, 2020 |
| Last update posted | Nov 19, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: